<?xml version="1.0" encoding="UTF-8"?>
<Label drug="dopamine1" track="TAC2017_ADR">
  <Text>
    <Section name="adverse reactions" id="S1">    ADVERSE REACTIONS

  The following adverse reactions have been observed, but there are not enough data to support an estimate of their frequency.



     Cardiovascular System    ventricular arrhythmiaatrial fibrillationectopic beatstachycardiaanginal painpalpitationcardiac conduction abnormalitieswidened QRS complexbradycardiahypotensionhypertensionvasoconstriction



     Respiratory System    dyspnea



     Gastrointestinal System    nauseavomiting



     Metabolic/Nutritional System    azotemia



     Central Nervous System    headacheanxiety



     Dermatological System    piloerection



     Other    Gangrene of the extremities has occurred when high doses were administered for prolonged periods or in patients with occlusive vascular disease receiving low doses of dopamine HCl.
</Section>
  </Text>
  <Mentions />
  <Relations />
  <Reactions />
</Label>
